Quest PharmaTech Inc - Asset Resilience Ratio

Latest as of January 2021: 0.00%

Quest PharmaTech Inc (QPT) has an Asset Resilience Ratio of 0.00% as of January 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Explore Quest PharmaTech Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.

Liquid Assets

CA$0.00

≈ $0.00 USD Cash + Short-term Investments

Total Assets

CA$175.61 Million

≈ $127.04 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2021)

This chart shows how Quest PharmaTech Inc's Asset Resilience Ratio has changed over time. See defensive interval ratio of Quest PharmaTech Inc to measure how many days the company can operate on defensive assets alone.

Liquid Assets Composition Over Time

This chart breaks down Quest PharmaTech Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see QPT total asset value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CA$0.00	0%
Short-term Investments	CA$0.00	0%
Total Liquid Assets	CA$0.00	0.00%

Asset Resilience Insights

Limited Liquidity: Quest PharmaTech Inc maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Quest PharmaTech Inc Industry Peers by Asset Resilience Ratio

Compare Quest PharmaTech Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
BRITANNIA LIFE SCIENCES F:L020	Biotechnology	63.76%
Revolution Medicines Inc NASDAQ:RVMD	Biotechnology	65.10%
argenx NV ADR NASDAQ:ARGX	Biotechnology	10.93%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Abivax SA PA:ABVX	Biotechnology	2.34%
ABCELLERA BIOLOGICS F:8QQ	Biotechnology	29.87%

Annual Asset Resilience Ratio for Quest PharmaTech Inc (2017–2021)

The table below shows the annual Asset Resilience Ratio data for Quest PharmaTech Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2021-01-31	0.00%	CA$0.00 ≈ $0.00	CA$175.61 Million ≈ $127.04 Million	--
2020-01-31	6.74%	CA$300.00K ≈ $217.02K	CA$4.45 Million ≈ $3.22 Million	-46.85pp
2019-01-31	53.59%	CA$3.11 Million ≈ $2.25 Million	CA$5.81 Million ≈ $4.20 Million	-31.49pp
2018-01-31	85.08%	CA$10.88 Million ≈ $7.87 Million	CA$12.78 Million ≈ $9.25 Million	+12.28pp
2017-01-31	72.80%	CA$8.27 Million ≈ $5.99 Million	CA$11.37 Million ≈ $8.22 Million	--

pp = percentage points

About Quest PharmaTech Inc

V:QPT Canada Biotechnology

Market Cap

$2.45 Million

CA$3.38 Million CAD

Market Cap Rank

#29773 Global

#1450 in Canada

Share Price

CA$0.02

Change (1 day)

+0.00%

52-Week Range

CA$0.02 - CA$0.05

All Time High

CA$0.25